Erratum: Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?

被引:0
|
作者
C Massard
J-J Voigt
A Laplanche
S Culine
A Lortholary
R Bugat
C Theodore
F Priou
M-C Kaminsky
T Lesimple
X Pivot
B Coudert
J-Y Douillard
Y Merrouche
K Fizazi
机构
来源
British Journal of Cancer | 2008年 / 99卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Correction to: British Journal of Cancer (2008) 97, 857–861, doi:10.1038/sj.bjc.6603942 The authors of the above paper, first published in October 2007, would like to add the following acknowledgement to their paper: We thank Programme Hospitalier de Recherche Clinique (PHRC).
引用
收藏
页码:1959 / 1959
相关论文
共 50 条
  • [1] Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    Massard, C.
    Voigt, J-J
    Laplanche, A.
    Culine, S.
    Lortholary, A.
    Bugat, R.
    Theodore, C.
    Priou, F.
    Kaminsky, M-C
    Lesimple, T.
    Pivot, X.
    Coudert, B.
    Douillard, J-Y
    Merrouche, Y.
    Fizazi, K.
    BRITISH JOURNAL OF CANCER, 2007, 97 (07) : 857 - 861
  • [2] Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy?
    C Massard
    J-J Voigt
    A Laplanche
    S Culine
    A Lortholary
    R Bugat
    C Theodore
    F Priou
    M-C Kaminsky
    T Lesimple
    X Pivot
    B Coudert
    J-Y Douillard
    Y Merrouche
    K Fizazi
    British Journal of Cancer, 2007, 97 : 857 - 861
  • [3] Carcinoma of an unknown primary: are EGF receptor, Her-2/neu, and c-Kit tyrosine kinases potential targets for therapy? (vol 97, pg 857, 2008)
    Massard, C.
    Voigt, J-J
    Laplanche, A.
    Culine, S.
    Lortholary, A.
    Bugat, R.
    Theodore, C.
    Priou, F.
    Kaminsky, M-C
    Lesimple, T.
    Pivot, X.
    Coudert, B.
    Douillard, J-Y
    Merrouche, Y.
    Fizazi, K.
    BRITISH JOURNAL OF CANCER, 2008, 99 (11) : 1959 - 1959
  • [4] Primary adrenocortical tumors: EGFR, c-Kit and Her-2/neu receptor staining patterns.
    Samnotra, V
    Memoli, VA
    Ernstoff, MS
    Tretter, CPG
    Heaney, JA
    Korc, M
    Farell, TJ
    Simmons, P
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 445S - 445S
  • [5] RECEPTOR TYROSINE KINASES IN SINONASAL UNDIFFERENTIATED CARCINOMAS-EVALUATION FOR EGFR, c-KIT, AND HER2/neu EXPRESSION
    Chernock, Rebecca D.
    Perry, Arie
    Pfeifer, John D.
    Holden, Joseph A.
    Lewis, James S., Jr.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2009, 31 (07): : 919 - 927
  • [6] HER-2/neu and CD117 (C-kit) overexpression in hepatocellular and pancreatic carcinoma
    Potti, A
    Ganti, AK
    Tendulkar, K
    Chitajallu, S
    Sholes, K
    Koch, M
    Kargas, S
    ANTICANCER RESEARCH, 2003, 23 (3B) : 2671 - 2674
  • [7] C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu
    Diallo, R
    Rody, A
    Jackisch, C
    Ting, E
    Schaefer, KL
    Kissler, S
    Karn, T
    Geddert, H
    Engels, K
    Kaufmann, M
    Gabbert, HE
    Shroyer, KR
    Poremba, C
    HUMAN PATHOLOGY, 2006, 37 (02) : 205 - 211
  • [8] HER-2/neu and c-kit (CD117) overexpression in primary mucosal melanoma of the head and neck
    Plasil, BJ
    Husein, O
    Frankel, WL
    Rawal, Y
    Prasad, ML
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2004, 122 (04) : 650 - 650
  • [9] C-KIT expression in ductal carcinoma in situ of the breast: co-expression with HER-2/neu.
    Diallo, R
    Rody, A
    Schaefer, KL
    Geddert, H
    Shroyer, KR
    Gabbert, HE
    Kaufmann, M
    Jackisch, C
    Poremba, C
    BREAST CANCER RESEARCH AND TREATMENT, 2005, 94 : S138 - S139